Evidence map›Paper›PMID 22350751›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2012

The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience.

Miriam Puls, Tanja Viel, Bernhard C Danner, Claudius Jacobshagen, Nils Teucher, Gunnar Hanekop, Friedrich Schöndube, Gerd Hasenfuss, Ralf G Seipelt, Wolfgang Schillinger

Abstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters.Clinical research in cardiology : official journal of the German Cardiac Society · 2014
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Development of a risk score for outcome after transcatheter aortic valve implantation.Clinical research in cardiology : official journal of the German Cardiac Society · 2014
    Article
  13. Article
  14. Can postoperative mean transprosthetic pressure gradient predict survival after aortic valve replacement?Clinical research in cardiology : official journal of the German Cardiac Society · 2014
    Observational
  15. Article
  16. Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access.Clinical research in cardiology : official journal of the German Cardiac Society · 2013
    Article
  17. Article
  18. The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation?Clinical research in cardiology : official journal of the German Cardiac Society · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miriam PulsDepartment of Cardiology and Pneumology, Georg August University of Goettingen, Göttingen, Germany.
Tanja Viel
Bernhard C Danner
Claudius Jacobshagen
Nils Teucher
Gunnar Hanekop
Friedrich Schöndube
Gerd Hasenfuss
Ralf G Seipelt
Wolfgang Schillinger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscatheter aortic valve implantation (TAVI) has recently developed into an acceptable alternative to conventional surgery in high-risk patients. However, information on the identification of patients gaining most benefit from this procedure is still limited. The aim of this study was to evaluate safety and efficacy of TAVI in different patient cohorts.

methodsBetween August 2008 and December 2010, 180 high-risk patients underwent TAVI at our institution (97 transapical and 83 transfemoral approaches). Periprocedural complications as well as mortality and incidence of MACCE during follow-up were recorded.

resultsMean age was 82 ± 5 years, and mean logistic EuroScore 27 ± 14%. In the total cohort, 30-day mortality was 8.9% and 12-month survival (according to Kaplan-Meier-analysis) 72%, with no significant differences between the two approaches. However, a significant difference in survival was obvious after stratification of patients according to logistic EuroScore mortality estimates. Survival proportions at 1 year were 62% in patients with logistic EuroScore >40%, 71% in patients with EuroScore 20-40% and 80% in octogenarians with EuroScore <20% (P = 0.009). Furthermore, the observed median event-free survival as an indicator for morbidity ranged between 315 days in the first, 442 days in the second and 710 days in the third group (P = 0.1).

conclusionsTAVI proved to be feasible with reproducible results. However, mortality and rehospitalization rates were considerably high in specific patient cohorts, suggesting that the risk-to-benefit ratio of TAVI should be validated individually. In the present study, octogenarians with logistic EuroScore <20% could be identified as candidates apparently gaining high benefit from the procedure.

Indexed as

AgedAged, 80 and overAge FactorsAortic Valve StenosisCardiac CatheterizationChi-Square DistributionDisease-Free SurvivalFemaleGermanyHeart Valve Prosthesis ImplantationHospital MortalityHumansKaplan-Meier EstimateLogistic ModelsMalePatient Readmission

Identifiers

PMID22350751
PMCPMC3377897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.